Survivin - an inhibitor of apoptosis and a new therapeutic target in cancer. Radiol Oncol [Internet]. 2003 Sep. 1 [cited 2026 Oct. 6];37(3). Available from: https://www.radioloncol.com/index.php/ro/article/view/1366